CARLSBAD, Calif., Oct. 4, 2018 /PRNewswire/ -- Qualigen, Inc., a privately-owned company that provides novel diagnostic andtherapeutic technologies for the treatment of cancer and infectious diseases, announced today the issuance of China Patent Number ZL 2017 3 0590489.7, which covers the design of Qualigen's novel FastPack 2.0 Reagent Pouch. The patent, which provides
About Qualigen, Inc.Qualigen, Inc. is a medical device company focused on the development, production and commercialization of innovative medical technologies, including its flagship FastPack® point-of-care immunoassay system and novel therapeutic technologies for treatment of cancers and infectious diseases. For more information, visit www.qualigeninc.com.
View original content:http://www.prnewswire.com/news-releases/qualigen-announces-new-patent-issued-for-its-fastpack-diagnostic-technology-in-china-300725010.html
SOURCE Qualigen, Inc.
Subscribe to our Free Newsletters!